Skip to content
OpenCapital
Get started

ePlus PLUS Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.09M+76.6%

Other financials

Income statement

See full
Revenue$581.6M+21.7%
Gross profit$147.1M+10.7%
Operating income$37.6M+52.0%
Net income$25.0M+14.9%
EPS (diluted)$0.95+14.5%

Balance sheet

See full
Cash & equivalents$410.8M+5.5%
Total debt$16.3M-80.9%
Total equity$1.1B+10.1%
Total assets$1.8B-4.2%

Cash flow

See full
Operating cash flow-$87.4M-233%
CapEx$1.2M-36.5%
Free cash flow-$30.2M-119%

Valuation

See full
Market cap$2.11B+22.3%

Profitability

See full
Gross margin25.2%-0.4pp
Operating margin6.8%+1.8pp
Net margin5.4%+0.2pp
FCF margin-10.4%-26.4pp

Returns & leverage

See full
Return on equity13%+1.8pp
Debt / equity0×-0.1×
Current ratio2.2×+0.5×

Where this comes from

Reported directly by ePlus in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: ePlus’s 10-K, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about ePlus's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ePlus's indefinite-lived research and development assets?
ePlus (PLUS) reported indefinite-lived research and development assets of $374K in Q1 2026.
What is the long-term trend for ePlus's indefinite-lived research and development assets?
Over 2 years (2024 to 2026), ePlus's indefinite-lived research and development assets has grown at a -13.7% compound annual growth rate (CAGR), from $502K to $374K.
What does indefinite-lived research and development assets mean?
Refers to acquired in-process research and development assets that are not yet subject to amortization because their useful life is considered indefinite until completion or abandonment. This represents the company's investment in future innovation and technological capabilities. It is a key indicator of the company's long-term growth strategy and potential for future product development.